Does Variation in Either Age at Start of Therapy or Duration of Therapy Make Chemoprevention with Finasteride Cost-Effective?

    April 2011 in “ The Journal of Urology
    Suzanne Stewart, Charles D. Scales, Judd W. Moul, Shelby D. Reed
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study concluded that finasteride is most cost-effective for prostate cancer chemoprevention when started at age 65 and continued until age 80.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →